EUVIMEDEUVIMED entdecken
Crossref

A Phototherapy Nanosensitizer-Unlocked Multihit Strategy to Inhibit Tumor Stemness and Potentiate Sorafenib Response in Hepatocellular Carcinoma

Tian Qin, Huaze Lu, Qin Wang, Ying Deng, Jingtong Zeng, Yuanyuan Chen, Xinhong Liao iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c13211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Tian Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Guangxi Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibCarcinoma, HepatocellularLiver NeoplasmsNeoplastic Stem CellsAntineoplastic AgentsPhototherapyPhotosensitizing AgentsHumansMiceAnimalsCell Line, TumorPhotochemotherapyPhosphorusMice, Inbred BALB C

Stichwörter der Autor:innen

black phosphorus nanosheetferroptosishepatocellular carcinomasorafenib resistancetumor stemness

Substanzen

SorafenibAntineoplastic AgentsPhotosensitizing AgentsPhosphorus

Autor:innen und Institutionen

  • Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Department of Hepatobiliary, Pancreas and Spleen Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
  • Department of Medical Ultrasound, Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning 530021, China.

ORCID-Profile: Xinhong Liao

Förderung

  • Guangxi Science and Technology Program

Zitieren

APA

Qin, T., Lu, H., Wang, Q., Deng, Y., Zeng, J., Chen, Y., & Liao, X. (2025). A Phototherapy Nanosensitizer-Unlocked Multihit Strategy to Inhibit Tumor Stemness and Potentiate Sorafenib Response in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c13211

Vancouver

Qin T, Lu H, Wang Q, Deng Y, Zeng J, Chen Y, et al. A Phototherapy Nanosensitizer-Unlocked Multihit Strategy to Inhibit Tumor Stemness and Potentiate Sorafenib Response in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c13211

BibTeX
@article{Qin2025,
  author = {Qin, Tian and Lu, Huaze and Wang, Qin and Deng, Ying and Zeng, Jingtong and Chen, Yuanyuan and Liao, Xinhong},
  title = {A Phototherapy Nanosensitizer-Unlocked Multihit Strategy to Inhibit Tumor Stemness and Potentiate Sorafenib Response in Hepatocellular Carcinoma},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c13211}
}
Kostenlos starten →